Recombinant human erythropoietin enhances superoxide production by FMLP- stimulated polymorphonuclear leukocytes in hemodialysis patients

Kidney International

Volumn 52, Issue 5, 1997, Pages 1390-1394

  Chen, Hung Chun ^a   Tsai, Jer Chia ^a   Tsai, Juei Hsiung ^a   Lai, Yung Hsiung ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

FMLP; Hemodialysis; Polymorphonuclear leukocytes; Recombinant human erythropoietin; Superoxide production

Indexed keywords

FORMYLMETHIONYLLEUCYLPHENYLALANINE; HEMOPOIETIC GROWTH FACTOR; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E2; RECOMBINANT ERYTHROPOIETIN; SUPEROXIDE; ZYMOSAN;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HEMATOPOIESIS; HEMODIALYSIS; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MALE; NEUTROPHIL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS;

EID: 0030662296     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.466     Document Type: Article

References (43)

1. NISHI N, NAKAHATA T, JOIKE K, TAKAGI M, NAKAMURA K, AKABANE T: Induction of mixed erythroid-megakaryocyte colonies and biopotential blast cell colonies by recombinant human erythropoietin in serum free culture. Blood 76:133-1335, 1990
2. GEISSLER D, KONWALINKA G, PESCHEL C, BALCKER B, LECHNER K: The role of erythropoietin, megakaryocyte colony-stimulating factor, and T-cell-derived factors on human megakaryocyte colony formation: Evidence for T-cell-mediated and T-cell-independent stem cell proliferation. Exp Hematol 15:84-853, 1987
3. GEISSLER K, STOCKENHUBER F, HINTERBERGER W, BALCKE B, LECHNER K: Recombinant human erythropoietin: A multipotential hemopoietic growth factor in vivo and in vitro. Contrib Nephrol 87:1-10, 1990
4. PFAFFL W, GROSS HJ, NEUMEIER D, NATTERMAN U, SAMTLEBEN W, GURLAND HJ: Lymphocyte subset and delayed cutaneous hypersensitivity in hemodialysis patients receiving recombinant human erythropoietin. Contrib Nephrol 66:195 -204, 1988
5. PACZEK L, SCHAEFER RM, HEIDLAND A: Improved function of B lymphocytes in dialysis patients treated by recombinant human erythropoietin. Contrib Nephrol 87:36-41, 1990
6. CHRISTENSEN RD, KOENIG JM, VISKOCHI DH, ROTHSTEIN G: Downmodulation of neutrophil production by erythropoietin in human hematopoietic clones. Blood 74:817-822, 1989
7. CHRISTENSEN RD, LIECHTY KW, KOENIG JM, SCHIBLER KR, OHLS RK: Administration of erythropoietin to newborn rats results in diminished neutrophil production. Blood 78:1241-1246, 1991
8. AKIZAWA T, KINUGASA E, KITAOKA T, KUSHIKAWA S: Effects, of recombinant human erythropoietin and correction of anemia on platelet function in hemodialysis patients. Nephron 58:400-406, 1991
9. BOOGAERTS MA, ZACHEE P, EMONDS MP, GOOSSENS W, VERWILGHEN RL, LINS R: Erythrocytes as suicidal endogenous scavengers in immune triggered granulocyte mediated vascular damage. Thromb Haemost 58/1:104, 1987
10. MAHER ER, WICKENS DG, GRIFFIN JFA, KYLE P, CURTIS JR, DORMANDY TL: Increased free-radical activity during haemodialysis. Nephrol Dial Transplant 2:169-171, 1988
11. ZACHEE P, EMONDS MP, LINS RL, BOOGALRTS MA: Red blood cells, the scavenger for toxic free radicals during haemodialysis. Nephrol Dial Transplant 4:104-105, 1990
12. SCHMIDTMANN S, VON BAEUR R, PRECHT K: Free radicals induce increased lysis of red blood cells after haemodialysis. Nephrol Dial Transplant 5:600-603, 1990
13. ZACHEE P, FERRANT A, DAELEMANS R, COOLEN L, GOOSSENS W, LINS RL, COUTTENYE M, DE BROE ME, BOOGAERTS MA: Oxidative injury to erythrocytes. cell rigidity and splenic hemolysis in hemodialyzed patients before and during erythropoietin treatment. Nephron 65:288-293, 1993
14. BOYUM A: Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21(Suppl 97):77-89, 1968
15. BABIOR BM, KIPNES RS, CURNUTTE JJ: Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 52:791-794, 1970
16. GURNEY CW, JACOBSON LO, GOLDWASSER E: The physiologic and clinical significance of erythropoietin. Ann Intern Med 49:353-379, 1958
17. HAMPERS CL, STREIFF R, NATHAN DG: Megaloblastic hematopoiesis in uremia and in patients on long-term dialysis. N Engl J Med 276:551-554, 1967
18. KAISER L, SCHWARTZ KA: Aluminum-induced anemia. Am J Kidney Dis 6:348-352, 1985
19. WEIBERG SG, LUBIN A, WIENER S: Myelofibrosis and renal osteodystrophy. Am J Med 63:755-764, 1977
20. LOGE JP, LANGE RD, MOORE CV: Characterization of the anemia associated with chronic renal insufficiency. Am J Med 24:4-18, 1958
21. DELWICHE F, SEGAL GM, ESCHBACH JW, ADAMSON JW: Hematopoietic inhibitors in chronic renal failure: Lack of in vitro specificity. Kidney Int 29:641-648, 1986
22. ESCHBACH JW, FUNK D, ADAMSON JW, KUHN I, SCRAB̈NER BH, FINCH CA: Erythropoiesis in patients with renal failure undergoing chronic dialysis. N Engl J Med 276:653-658, 1976
23. KOCH KM, PATYNA WD, SHALDON S, WERNER E: Anemia of the regular hemodialysis patients and its treatment. Nephron 12:4115-419, 1974
24. SOCKS J, OFFERMAN L, MODEL CB, DORMANDY TL: The susceptibility to auto-oxidation of human red cell lipids in health and disease. Br J Haematol 23:713-724, 1972
25. ROSENMUND A, BINSWANGER U, STRAUB PW: Oxidative injury to erythrocytes. cell rigidity, and splenic hemolysis in hemodialyzed uremic patients. Ann Intern Med 82:460-465, 1975
26. KIKUCHI Y, KOYAMA T, KOYAMA Y, TOZAWA S, ARAI T, HORIMOTO M, KAKIUCHI Y: Red blood cell deformability in renal failure. Nephron 30:8-14, 1982
27. DELMAS-BEAUVIEUX MC, COMBE C, PEUCHANT E, CARBONNEAU MA, DUBOURG L, PRECIGOUT V, APARICIO M, CLERC M: Evaluation of red blood cell lipoperoxidation in hemodialysed patients during erythropoietin therapy supplemented or not with iron. Nephron 69:404-410, 1995
28. TURI S, NEMETH I, VARGA H, BODROGI T, MATKOVICS B: The effect of erythropoictin on the cellular defence mechanism of red blood cells in children with chronic renal failure. Pediatr Nephrol 6:536-541, 1992
29. ZEHNDER C, BLUMBERY A: Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis. Clin Nephrol 31:55-59, 1989
30. COTES PM, PIPPARD MJ, REID CDL, WINEARLS CG, OLIVER DO, ROYSTON JP: Characterization of the anaemia of chronic renal failure and the mode of its correction by a preparation of human erythropoietin. An investigation of the pharmacokinetics of intravenous erythropoietin and its effect on erythrokinetics. Q J Med 70:113-137, 1989
31. ESCHBACH JW: The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin. Kidney Int 35:134-148, 1989
32. VEYS N, VANHOLDER R, RINGOIR S: Correction of deficient phagocytosis during erythropoietin treatment in maintenance hemodialysis patients. Am J Kidney Dis 515:358-363, 1992
33. BERTON G, ZENI L, CASSATELLA MA, ROSSI F: Gamma interferon is able to enhance the oxidative metabolism of human neutrophils. Biochem Biophys Res Commun 138:1276-1282, 1986
34. BOELAERT J, CANTINIEAUX B, HARIGA C: Recomhinant erythropoietin reverses polymorphonuclear granulocyte dysfunction in iron-over-loaded dialysis patients. Nephrol Dial Transplant 5:504-507, 1990
35. OKUDA A, KUBOTA M, SAWADA M, KOISHI S, KATAOKA A, BESSHO R, USAMI I, LIN YW, ADACHI S, FURUSHO K: Methotrexate inhibits superoxide production and chemotaxis in neutrophils activated by granulocyte colony-stimulating factor. J Cell Physiol 168:183-187, 1996
36. GRYGLEWSKI RJ, SZEKLIK A, WANDZILAK M: The effect of six prostaglandins, prostacycline and iloprost on generation of superoxide anion by zymosan or formyl-methionyl-leucyl-phenylalaninc. Biochem Pharmacol 36:4209-4213, 1987
37. FANTONE JC, KINNES DA: Prostaglandin E1 and prostaglandin I, modulation of superoxide production by human neutrophils. Biochem Biophys Res Commun 113:506-512, 1983
38. YOUSSOUFIAN H, LONGMORE G, NEUMANN D, YOSHIMURA A, LODISH HF: Structure, function, and activation of the erythropoietin receptor. Blood 81:2223-2236, 1993
39. SNYDERMAN R, PIKE MC: Chemoattractant receptors on phagocytic cells. Ann Rev Imnninol 2:257-281, 1984
40. LAI KN, LEUNG JCK: Heat-aggregated IgA prepared from patients with IgA nephropathy increases calcium mobilization and superoxide production of human neutrophils in vitro. Nephron 64:129-135, 1993
41. LAI KN, LEUNG JCK, LI PKT: Heat-aggregated IgA prepared from patients with IgA nephropathy increases priming of human neutrophils to produce inositol triphosphate following FMet-Leu-Phe stimulation in vitro. Nephron 69:1-8, 1995
42. MIURA Y, MIURA O, IHLE JN, AOKI N: Activation of the mitogenactivated protein kinase pathway by the erythropoietin receptor. J Biol Chem 269:29962-29969, 1994
43. ZU YL, AI Y, GILCHRIST A, LABADIA ME, SHA AFI RI, HUANG CK: Activation of MAP kinase-activatcd protein kinase 2 in human neutrophils after phorbol ester or fMLP peptide stimulation. Blood 87:5287-5296, 1996.